Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty

New England Journal of Medicine

Volumn 339, Issue 23, 1998, Pages 1672-1678

  Erbel, Raimund ^a   Haude, Michael ^a   Höpp, Hans W ^b   Franzen, Damian ^b   Rupprecht, Hans Jürgen ^c   Heublein, Bernd ^d   Fischer, Klaus ^d   De Jaegere, Peter ^e   Serruys, Patrick ^e   Rutsch, Wolfgang ^f   Probst, Peter ^g  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PHENPROCOUMON;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BYPASS SURGERY; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CROSSOVER PROCEDURE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESTENOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY VESSELS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RECURRENCE; STENTS; THROMBOSIS;

EID: 0032480946     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812033392304     Document Type: Article

References (38)

1. Rupprecht HJ, Brennecke R, Bernhard G, Erbel R, Pop T, Meyer J. Analysis of risk factors for restenosis after PCTA. Cathet Cardiovasc Diagn 1990;19:151-9.
2. Serruys PW, Foley DP, Kirkeeide RL, King SB III. Restenosis revisited: insights provided by quantitative coronary angiography. Am Heart J 1993; 126:1243-67
3. Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77C-81C.
4. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-7.
5. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographie followup of 229 patients. J Am Coll Cardiol 1988;12:616-23.
6. Bauters C, Lablanche JM, McFadden EP, Leroy F, Bertrand ME. Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilatation for the first restenosis. J Am Coll Cardiol 1992;20:845-8.
7. Teirstein PS, Hoover C, Ligon B, et al. Repeat restenosis: efficacy of the third and fourth coronary angioplasty. J Am Coll Cardiol 1987;9:Suppl A: 63A. abstract.
8. Ellis SG, Savage M, Fischman D, et al. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries: initial results of a multicenter experience. Circulation 1992;86:1836-44.
9. Quigley PJ, Hlatky MA, Hinohara T, et al. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol 1989;63:409-13.
10. Faxon DP, Sanborn TA, Haudenschild CC, Ryan TJ. Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol 1984;53:72C-76C.
11. Hirshfeld JW Jr, Schwartz JS, Jugo R, et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991;18:647-56.
12. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-93.
13. Bourassa MG, Lesperance J, Eastwood C, et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-76.
14. Kuntz RE, Gibson CM, Nobuyoshi M, Bairn DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993;21:15-25.
15. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-20.
16. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-6.
17. Haude M, Erbel R, Straub U, Dietz U, Schatz R, Meyer J. Results of intracoronary stents for management of coronary dissection after balloon angioplasty. Am J Cardiol 1991;67:691-6.
18. Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol 1993;21:26-34.
19. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
20. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
21. Haude M, Erbel R. Coronary stenting for the treatment of restenosis after percutaneous transluminal coronary angioplasty. J Interventional Cardiol 1994;7:341-6.
22. Erbel R, Schatz R, Dietz U, et al. Ballondilatation und koronare Gefäβstützenimplantation. Z Kardiol 1989;78:71-7.
23. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation 1991;83:148-61.
24. Reiber JHC, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-8.
25. Gardner MJ, Altmann DG. Statistics with confidence. In: Gardner MJ, Altmann DG, eds. Statistics with confidence: confidence intervals and statistical guidelines. London: British Medical Journal, 1992:50-63.
26. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
27. Colombo A, Ferraro M, Itoh A, Martini G, Blengino S, Finci L. Results of coronary stenting for restenosis. J Am Coll Cardiol 1996;28:830-6.
28. Mudra H, Klauss V, Blasini R, et al. Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter. Circulation 1994;90:1252-61.
29. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
30. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412-22.
31. Debbas NMG, Sigwart U, Eckhout E, et al. Intracoronary stenting of restenosis: long-term follow-up: a single center experience. J Invasive Cardiol 1996;8:241-8.
32. Savage MP, Goldberg S, Fischman DL, Zalewski A, Walinsky P. Therapeutic strategies for the restenotic lesion. In: Ellis JG, Holmes DR Jr, eds. Strategic approaches in coronary intervention. Baltimore: Williams & Wilkins, 1996:361-9.
33. Schmitz HJ, Erbel R, Meyer J, von Essen R. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty. Am Heart J 1996;131:884-91.
34. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation 1993;88:1310-23.
35. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.
36. Schömig A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulation therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
37. Detre K, Holubkov R, Kelsey S, et al. One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1989;80:421-8.
38. Sridhar K., Goldberg S. Treatment of closure after coronary intervention. In: Ellis SG, Holmes DR Jr, eds. Strategic approaches in coronary intervention. Baltimore: Williams & Wilkins, 1996:618-26.